| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.48 | 0.001 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |